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Heme oxygenase (HO) is the only known mammalian enzyme that catalyzes the degradation of heme and the production of carbon monoxide, a gaseous signaling molecule.^[@ref1]^ Heme serves multiple cellular and systemic roles ranging from oxygen carrier in globins^[@ref2],[@ref3]^ and electron transport in cytochromes^[@ref4]^ to gas sensor in various proteins, i.e., *Ec* DOS,^[@ref5],[@ref6]^ soluble guanylate cyclase,^[@ref7]^ and CooA.^[@ref8]^ However, free heme can be commensurably toxic because it undergoes Fenton-like reactions, producing reactive oxygen species, which in turn induce oxidative stress and cell death.^[@ref9]^ The concentration of free heme has been estimated to be very low, with measured values of 0.1 μM or below in erythrocytes.^[@ref10]^

By degrading pro-oxidant free heme, HO confers tissue protection. In a reaction that requires three equivalents of oxygen and seven electrons supplied by NADPH-dependent cytochrome P450 reductase, HO cleaves the heme ring to yield CO, iron, and biliverdin.^[@ref11]−[@ref13]^ Biliverdin is subsequently reduced to bilirubin by biliverdin reductase. In addition to removing free heme, the end products of the HO reaction have cytoprotective effects. HO-derived iron drives the synthesis of ferritin, which serves as a protective sink for intracellular redox-active iron,^[@ref14]^ bilirubin circulates in an albumin-bound form in the blood and acts as an antioxidant,^[@ref15]^ and CO exerts anti-inflammatory, antiapoptotic, and antiproliferative effects.^[@ref1]^ CO also functions in oxygen sensing and acts as a signaling molecule that can stimulate soluble guanylate cyclase to produce guanosine 3′,5′-monophosphate.^[@ref16]^

Two principal isozymes of HO, referred to as HO1 and HO2, have been identified in mammals.^[@ref17]^ HO1 and HO2 are products of separate genes^[@ref18]^ and differ in their regulation and tissue distribution. The first HO to be identified,^[@ref19]^ HO1 is an inducible form of the enzyme and is present in high concentrations in tissues responsible for heme catabolism, e.g., liver, spleen, bone marrow, and senescent red blood cells. In most other tissues, HO1 levels typically are low to undetectable under basal conditions, but rapidly increase when cells are subjected to diverse chemical or physical stresses. HO1 is the same inducible protein that has been known as heat shock protein 32.^[@ref20]^ HO2 expression, by contrast, is constitutive and predominantly in brain, testes, and neural tissues. Though it does not respond to transcriptional activation by environmental stress, HO2 has a glucocorticoid response element in its promoter region, which, in the presence of corticosterone, may modulate HO2 expression in a tissue-specific manner in the brain^[@ref21]^ and in an age-related fashion in testis.^[@ref22]^ Accordingly, *hmox2*, the gene encoding HO2 in rat testis was shown to manifest distinctly sized transcripts as well as differential expression through various developmental stages.^[@ref23]^ The perpetual presence of HO2 was conjectured to be vital for testicular function to counterpoise the reactive oxygen species produced by spermatozoa, with antioxidants biliverdin and bilirubin, generated from the HO2 reaction, and hence protect the extremely sensitive sperm cells from the damaging effects of oxygen radicals.^[@ref23]^

Structurally, HO2^[@ref24]^ has the same α-helical fold as HO1^[@ref25]^ with the imidazole nitrogen of a conserved histidine in the catalytic domain (His25 in HO1 and His45 in HO2) acting as a heme iron ligand. HO1 and HO2 are highly homologous (55% identity, 76% similarity for the human proteins) and are anchored to the microsomal membrane via a similar stretch of 20 hydrophobic residues at their C-termini.^[@ref16]^ Significant differences between these proteins lie in their N-termini, where HO2 contains an extra 30 amino acid segment, and in their C-termini between residues 240--295 (HO2 numbering). In this latter region, HO2, unlike HO1, contains two short amino acid stretches, each containing a Cys-Pro dipeptide identified as heme regulatory motifs (HRMs). Earlier studies in our lab have demonstrated that the two Cys residues in the C-terminal HRMs form a reversible thiol/disulfide redox switch that modulates the affinity of HO2 for heme as a function of redox poise,^[@ref26],[@ref27]^ although the physiological relevance of this has been questioned.^[@ref28]^ We will designate the forms of HO2 in which the two C-terminal Cys residues are in the reduced or oxidized (disulfide) state as HO2^R^ or HO2^O^, respectively. Furthermore, mutagenesis coupled with electron paramagnetic resonance (EPR) and magnetic circular dichroism studies indicated that in the HO2^R^ state, Cys265 can ligate to Fe^3+^-heme.^[@ref29]^ One possibility is that the thiolate of Cys265 could ligate to the catalytic site heme; however, the heme in HO2 is securely sandwiched between two helices,^[@ref24]^ as in HO1.^[@ref25],[@ref30]^ The other scenario is that the HRMs form an independent heme binding site(s), as suggested by studies from the Maines' laboratory.^[@ref31]^

While earlier X-ray crystallographic studies of HO2 revealed interesting insights into the catalytic core, they failed to provide any structural insight into the HRMs (C~265~P~266~ and C~282~P~283~) encompassing the C-terminal region.^[@ref24]^ Of the 288-residue soluble portion of HO2, one construct that successfully crystallized lacked the two HRM motifs and only consisted of residues 1--264. Furthermore, the electron density for residues 1--28 and 249--264 was not observed. Hence, a total of 68 residues, 28 and 40 at the N- and C-termini respectively, were missing in the crystal structure. Another 2.5 Å structure of soluble apo-HO2 (residues 1--288), containing the HRMs was obtained and deposited (pdb ID 4WMH); however, like the published structure of the core (1--264), only the electron density for residues 31--237 could be observed. Therefore, while biochemical studies have indicated an important functional role of HRMs as a redox switch that regulates heme binding to the enzyme,^[@ref26],[@ref27]^ a structural perspective of this redox-dependent differential regulation of substrate (heme) binding to HO2 was missing.

HRMs are found to modulate the activity of other heme-regulated proteins, such as the transcription factors, Bach1,^[@ref32],[@ref33]^ Rev-Erb,^[@ref34]^ and eukaryotic initiation factor 2α (elF2α) kinase.^[@ref35]^ Although important roles of the HRMs have been demonstrated by mutational analyses, there is little direct structural insight into how this motif regulates these systems. Using nuclear magnetic resonance (NMR), EPR, electron nuclear double resonance (ENDOR), and X-ray absorption (XAS) analyses, we have now shown that the two HRMs near the C-terminus of HO2 are in a disordered region. Our results indicate that, upon reduction of the disulfide bond between Cys265 and Cys282, the C-terminal region including the two HRMs interacts with the catalytic core of HO2 and that the cysteines in the HRMs directly interact with a second bound heme.

Materials and Methods {#sec2}
=====================

HO2 Expression and Purification {#sec2.1}
-------------------------------

The truncated form of human HO2(1--288) devoid of the sequence encoding for the membrane-spanning region at the C-terminus was cloned in a pET28a (Novagen) vector using the restriction sites NdeI and *Eco*RI. This resulted in a construct which contained the truncated *hmox2* gene preceded by a thrombin cleavage site and a His tag at the N-terminus.

The *hmox2*-containing pET28a plasmid was transformed into BL21-(λDE3) cells. Cells were grown in Luria Broth (LB) media containing 50 μg/mL kanamycin at 37 °C until they reached an *A*~600~ of 0.8--1.0, then were induced with 1.0 mM isopropyl β-[d]{.smallcaps}-1-thiogalactopyranoside and grown at 25 °C for another 18--20 h. Cells were harvested by centrifugation at 4000 rpm for 30 min at 4 °C in a Sorvall RC3C Plus centrifuge using an H6000 swinging bucket rotor, weighed, and frozen at −20 °C.

Approximately 8.0--10.0 g of cells obtained per liter of cell culture was resuspended in 50 mL of lysis buffer (50 mM Tris, 400 mM KCl, 4.0 mM imidazole, 0.05% Triton X-100 (v/v) pH 8.0). Into this suspension, EDTA-free protease inhibitor cocktail (Roche Applied Science) (1 tablet/50 mL) was added along with phenyl methyl sulfonyl fluoride (1.0 mM final concentration), DNAase I (5 units/mL), and a pinch of RNAase and lysozyme. The suspension was allowed to stir at 4 °C for approximately 30 min. Cells were then lysed by sonication for a total process time of 10 min with repetitive cycles of 7.5 s of pulse-on and pulse-off. This lysate was further pelleted by spinning at 30 000 rpm for 30 min in a Beckman L8-80M ultracentrifuge using a Type 45 Ti fixed angle rotor. The supernatant was loaded onto a Ni-nitrilotriacetic acid (Ni-NTA) (Qiagen) affinity column. After the column was washed extensively with lysis buffer, HO2 was eluted using a linear gradient of 20--250 mM imidazole contained in 50 mM Tris, 400 mM KCl, pH 8.0 buffer. The HO2 eluted in a broad band beginning at ∼50 mM imidazole. Aliquots of the fractions were run on SDS-polyacrylamide gels and stained with Coomassie blue to determine purity. Fractions with at least 95% purity were combined and dialyzed against 50 mM Tris, 150 mM KCl, 2.5 mM CaCl~2~, pH 8.0. The HO2 concentration was determined using ε~280~ = 23 505 M^--1^ cm^--1^.^[@ref36]^ HO2 was then treated with thrombin (3 units/mg HO2) at 4 °C for 16 h to cleave the N-terminal His tag, and the protein was loaded back onto the Ni-NTA column. The cleaved HO2 now eluted in the wash, and the His tag was retained.

The cleaved HO2 fractions were then incubated with benzamidine sepharose resin (GE Biosciences) to bind and hence remove thrombin, and then treated with 1 mM (final) 4-(2-aminoethyl) benzenesulfonylfluoride to ensure that any remaining thrombin activity was inactivated. Before use, the purified HO2 was dialyzed against an appropriate buffer and concentrated using Amicon Ultra-15 centrifugal filter units (Millipore) with a 10-kDa molecular weight cutoff.

Triple-Labeling of HO2 for NMR Studies {#sec2.2}
--------------------------------------

For expression of \[U-^2^H, ^15^N, ^13^C\]-HO2, the *hmox2*-containing pET28a plasmid was freshly transformed into BL21-(λDE3) and plated onto H~2~O-based LB medium.^[@ref37]^ From an isolated colony, overnight growth was started in 50 mL of H~2~O-based M9 minimal medium.^[@ref38]^ Cells were centrifuged the following day, washed 3--4 times with ^2^H~2~O-based minimal media, and then used to inoculate 1 L of ^2^H~2~O-M9 minimal medium (cell density dilution of 1/50), which was supplemented with vitamin mix (5.0 mg/L thiamine, 1.0 mg/L [d]{.smallcaps}-biotin, 1.0 mg/L choline chloride, 1.0 mg/L folic acid, 1.0 mg/L niacinamide, 1.0 mg/L [d]{.smallcaps}-pantothenic acid, 1.0 mg/L pyridoxal, 0.1 mg/L riboflavin)^[@ref39]^ and 1 mL trace elements solution from a 1000× stock made in 60 mM HCl (50 mM FeCl~3~, 20 mM CaCl~2~, 10 mM each of MnCl~2~ and ZnSO~4~, and 2 mM each of CoCl~2~, CuCl~2~, NiCl~2~, Na~2~MoO~4~ and H~3~BO~3~).^[@ref40]^ Furthermore, 1.0 g/L ^15^NH~4~Cl and 1.0 g/L \[^13^C, ^2^H\] glucose (Cambridge Isotope Laboratories) were added as sole nitrogen and carbon sources. Cells were allowed to grow at 37 °C for approximately 6 h until they reached an *A*~600~ = 0.8--1.0. At this point, cells were induced with 1.0 mM isopropyl β-[d]{.smallcaps}-1-thiogalactopyranoside and grown at 25 °C for another 18--20 h before harvesting by centrifugation. \[U-^2^H, ^15^N, ^13^C\]-HO2 was purified as described above. Electrospray ionization mass spectrometry analysis revealed the amount of label incorporation to be 99.8%.

NMR experiments were performed on HO2^O^ and HO2^R^ in both the apo and the Fe^3+^-heme containing (Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^) forms. For disulfide bond reduction, HO2 was transferred into an anaerobic chamber (Vacuum Atmospheres, Inc.) and reacted for 1 h with a 25-fold molar excess of anaerobically prepared Tris (2-carboxyethyl) phosphine hydrochloride (TCEP) (Thermo Scientific). TCEP was then removed by dialyzing the protein in an anaerobic buffer against 50 mM Tris-HCl, 50 mM KCl, pH 7.0. Once retrieved from the dialysis tubing, a sample of HO2 was reacted with 5,5′ dithiobis(nitrobenzoic acid) (DTNB)^[@ref41]^ to measure thiol groups. For this, approximately 5--10 μM HO2 was withdrawn in a 1 mL reaction volume in 50 mM Tris, 8 M urea, pH 8.5 buffer in a sealed cuvette. After the baseline was adjusted, the protein solution was treated with 50 μL of DTNB solution from a 10 mM stock. The absorbance at 412 nm was recorded and, using ε~412~ = 0.0136 μM^--1^ cm^--1^, the concentration of thiols was calculated.^[@ref26]^

To prepare NMR samples, heme was added to apo-HO2 from a stock solution freshly prepared in 15% dimethyl sulfoxide (DMSO), 0.1 M NaOH and buffered at pH 7.0. The heme concentration was determined by using ε~385~ = 58.4 mM^--1^ cm^--1^.^[@ref42]^ Heme was added to the protein solution in small increments, monitoring the increase in *A*~404~ until the ratio of absorbance of the Soret peak to that at 280 nm (*A*~404~/*A*~280~) was constant. Approximately 1.2 mM Fe^3+^-HO2^O^ and 0.67 mM Fe^3+^-HO2^R^ \[U-^2^H, ^15^N, ^13^C\]-HO2 in 50 mM Tris, 50 mM KCl pH 7.0 plus 10% ^2^H~2~O were used to conduct triple-resonance experiments for sequential backbone assignments.

^1^H-^15^N HSQC was performed also on zinc protoporphyrin (ZnPP)-bound HO2 to monitor any increase in the number of peaks upon substitution of paramagnetic heme with the diamagnetic ZnPP. ZnPP-bound HO2 was prepared similarly to heme-bound HO2 except that the concentration was determined using an extinction coefficient of ε~412~ = 87.4 mM^--1^ cm^--1^.^[@ref43]^

NMR Experiments for 3D Assignments {#sec2.3}
----------------------------------

All spectra were acquired at 30 °C on an 800 MHz Varian Inova instrument equipped with a four-channel pulsed-field gradient triple-resonance cold probe. Multidimensional experiments used for Cα, Cβ, C′, N, and HN assignments entailed: TROSY version of 2D ^1^H-^15^N heteronuclear single quantum coherence (HSQC) and 3D HN(CO)CA, HNCA, HNCACB, HN(CO)CACB, HNCO, and HN(CA)CO. All these experiments were based on those described in the literature, with minor modifications.^[@ref44]^ The acquisition parameters for the experiments are summarized in Table [1](#tbl1){ref-type="other"}.

###### Acquisition Parameters for NMR Experiments Performed on HO2[a](#tbl1-fn1){ref-type="table-fn"}

                      acquired data (complex points)   spectral width (Hz)                                                        
  ------------------- -------------------------------- --------------------- ------------- ---------------- --------------------- ----------------
  ^15^N/^1^H-HSQC     300 (^15^N)                                            4102 (^1^H)   2999.9 (^15^N)                         12019.2 (^1^H)
  HNCO                82 (^15^N)                       150 (^13^CO)          2396 (^1^H)   2500 (^15^N)     2749.9 (^13^CO)       12019.2 (^1^H)
  HN(CA)CO            82 (^15^N)                       150 (^13^CO)          1664 (^1^H)   2500 (^15^N)     2749.9 (^13^CO)       12019.2 (^1^H)
  HNCA                82 (^15^N)                       150 (^13^CA)          6080 (^1^H)   2500 (^15^N)     5500.2 (^13^CA)       30487.8 (^1^H)
  HN(CO)CA            82 (^15^N)                       150 (^13^CA)          6080 (^1^H)   2500 (^15^N)     5500.2 (^13^CA)       30487.8 (^1^H)
  HNCACB              82 (^15^N)                       300 (^13^CA,CB)       6080 (^1^H)   2500 (^15^N)     15000.9 (^13^CA,CB)   30487.8 (^1^H)
  HN(CO)CACB          82 (^15^N)                       300 (^13^CA,CB)       6080 (^1^H)   2500 (^15^N)     15000.9 (^13^CA,CB)   30487.8 (^1^H)
  ^13^C/^1^H-HSQC\*                                    600 (^13^C)           2432 (^1^H)                    16000 (^13^C)         12019.2 (^1^H)
  ^15^N/^1^H-HSQC\*   300 (^15^N)                                            2404 (^1^H)   4000 (^15^N)                           12019.2 (^1^H)
  HNCA\* (2D)         1 (^15^N)                        150 (^13^CA)          4102 (^1^H)   2500 (^15^N)     5500.2 (^13^CA)       12019.2 (^1^H)
  HN(CA)CO\* (2D)     1 (^15^N)                        150 (^13^CO)          4096 (^1^H)   2500 (^15^N)     2749.9 (^13^CO)       12019.2 (^1^H)
  HNCACB\* (2D)       1 (^15^N)                        300 (^13^CA,CB)       4102 (^1^H)   2500 (^15^N)     15000.9 (^13^CA,CB)   12019.2 (^1^H)

Experiments marked with asterisk (\*) were collected on selective ^15^N, ^13^C-Cys labeled-HO2.

Data were processed using NMRPipe^[@ref45]^ and analyzed using SPARKY.^[@ref46]^ Time-domain data in the acquisition dimension were zero-filled to the power of 2 and apodized with exponential/Gaussian window function. Mirror image linear prediction was applied to the indirect ^15^N dimension acquired with constant-time evolution. Data in the indirect dimensions were apodized with cosine bell function and zero-filled also to the power of 2. SAGA^[@ref47]^ and EZ-ASSIGN^[@ref48]^ programs were used for automated backbone resonance assignments, which are listed in the [Supporting Information](#notes-1){ref-type="notes"}.

Preparation of HO2 with Selective ^15^N, ^13^C-Cysteine and ^2^H-Cysteine Labeling {#sec2.4}
----------------------------------------------------------------------------------

The *Escherichia coli* cysteine auxotroph, BL21-(λDE3) *selB::kan cys51E*([@ref49]) (kindly provided by Dr. Paul Ortiz de Montellano, University of California, San Francisco), henceforth called *cysE*, was utilized in these preparations. The *cysE* gene in *E. coli* encodes for enzyme serine acetyltransferase, which catalyzes the conversion of serine to O-acetylserine during cysteine biosynthesis. Thus, the mutation in the *cysE* gene disrupts the cysteine biosynthetic pathway, allowing isotopically labeled cysteine to be incorporated into the protein by externally supplying it in the growth medium. Because of the kanamycin resistance of the *cysE* cells, the cells were transformed with the recombinant plasmid pGEX4T2 containing the truncated *hmox2* gene described previously^[@ref26]^ rather than the pET28a/ *hmox2* construct, which also has kanamycin resistance, as above.

Transformed *cysE* cells were plated on an LB-agar plate containing 100 μg/mL ampicillin, 50 μg/mL kanamycin, and 30 μg/L [l]{.smallcaps}-cysteine hydrochloride. Overnight growth was started in 50 mL of LB medium containing 100 μg/mL ampicillin, 50 μg/mL kanamycin, and 30 μg/L [l]{.smallcaps}-cysteine hydrochloride, inoculated with a single colony. Cells were pelleted and resuspended to a cell density dilution factor of 20 mL in 1 L of enriched M9 media. The enriched media was prepared by first autoclaving the M9 salt solutions containing 1.0 g/L NH~4~Cl and then supplementing with amino acids along with the vitamin and trace element solutions. A 1000× stock solution for both vitamins and trace elements was prepared in accord with the concentrations finally desired in the growth media and added separately. Amino acids were prepared as a 10× stock and autoclaved. The amino acid solution contained alanine, glutamate, leucine, and lysine, each at 4.0 g/L (required concentration in the growth medium of 400 mg/L), and arginine, asparagine, aspartic acid, glutamine, glycine, histidine, isoleucine, methionine, proline, phenylalanine, threonine, tyrosine, serine and valine, each at 2.0 g/L (required concentration of 200 mg/L). Tryptophan and ^15^N, ^13^C- cysteine or ^2^H-cysteine were directly added to the media at concentrations of 50 mg/L and 70 mg/L respectively. Finally, 2.0 mM filter-sterilized MgSO~4~, 5.0 g/L [d]{.smallcaps}-glucose, and antibiotics were added.

Growth conditions were similar to those stated above except that the cells were cultured for only 6 h after induction to avoid scrambling of the label. HO2 was purified on a glutathione sepharose 4B column and, subsequently, the GST domain was cleaved and separated as reported earlier.^[@ref26]^ Label incorporation was confirmed using chymotrypsin-digest followed by LC-MS/MS analysis. Labeled HO2^R^ was generated using the same TCEP reduction protocol described above. Samples for HSQC experiments were dialyzed against 50 mM NaH~2~PO~4~, 50 mM NaCl pH 7.0 instead of 50 mM Tris-HCl, 50 mM KCl, pH 7.0, to avoid the intense natural abundance peaks from Tris in the 2D ^1^H-^13^C HSQC experiments.

For the heme-bound HO2 (Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^) HSQC samples, heme was also added in a similar fashion as detailed above. Protein was then passed through a Zeba spin desalting column (7 kDa molecular weight cutoff) (Thermo Scientific), to remove excess heme and DMSO. Desalting the protein of DMSO was important because the later manifests an intense natural abundance ^13^C peak from methyl groups at approximately 2.6, 41.5 ppm (^1^H, ^13^C), around the same region where we expected to see Cβ carbon from cysteines involved in the disulfide bond in 2D ^1^H--^13^C HSQC.

Sample Preparation for X-ray Absorption Fine Structure (EXAFS) and Fe K-edge XAS Measurements {#sec2.5}
---------------------------------------------------------------------------------------------

EXAFS experiments were performed on wild type Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^ as well as on the Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^ states of the double mutants, C127A/C265A and C127A/C282A. While wild type HO2 was expressed and purified from the pET28a construct using Ni-affinity columns as described above, variants were made in pGEX4T2 and purified using the glutathione-affinity columns.^[@ref26]^ Each of the three protein samples was split with half of the samples reduced with TCEP, as described above. Thus, the XAS analyses were performed on six heme-bound samples: 2.0 mM wild type Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^, 1.0 mM C127A/C265A variants of Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^, and 1.0 mM C127A/C282A variants of Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^. All samples were made in 50 mM Tris, 50 mM KCl, pH 7.0. Proteins were mixed with 20% glycerol, transferred to the EXAFS cuvettes, and flash frozen in liquid nitrogen. Experiments were performed in triplicate on two separate HO2 preparations.

Fe K-edge XAS data on the solution samples were measured on beamline 7-3, which is the standard biological solution XAS beamline at SSRL under standard ring conditions of 3 GeV and ∼350 mA ring current. Other optical components used for the experiments were a Si(220) double-crystal monochromator for energy selection and a Rh-coated harmonic rejection mirror. Spectra were collected in the fully tuned configuration of the monochromator. Data on the solution samples were measured in fluorescence mode using a Canberra 30-element solid-state Ge detector. Internal energy calibration was accomplished by simultaneous measurement of the absorption of a Fe foil placed between two ionization chambers situated after the sample. The first inflection point of the foil spectrum was fixed at 7111.2 eV. Scans were monitored for photoreduction throughout the course of data collection, and every sample showed a small edge-shift associated with photoreduction. The effect of photoreduction was not observed in the EXAFS region. The Fe K-edge spectral comparisons presented here are single scan averages to eliminate effects of beam-related photoreduction. The EXAFS spectra presented for all data sets are 9--25 scan averages and were obtained at a similar signal-to-noise ratio. A second-order polynomial was fit to the pre-edge region and subtracted from the entire spectrum as background. A four-region spline of orders 2, 3, 3, and 3 was used to model the smoothly decaying postedge region. Data were normalized using the Pyspline^[@ref50]^ program by subtracting a cubic spline and assigning the edge jump to 1.0 at 7200 eV. Data were renormalized in Kaleidagraph for quantitation and comparison purposes.

Theoretical EXAFS signals, χ(k), were calculated using the program FEFF (Macintosh version 8.4)^[@ref51]−[@ref53]^ on *xyz* coordinates obtained from the crystal structure of cytochrome *c*. The structure used for the FEFF calculations was the truncated active site and included the heme group and the axial amino acid ligands. The theoretical models were fit to the data using EXAFSPAK.^[@ref54]^ The structural parameters varied during the fitting process were the bond distance (*R*) and the bond variance σ^2^, which is related to the Debye--Waller factor resulting from thermal motion, and static disorder of the absorbing and scattering atoms. The nonstructural parameter *E*~0~ (the energy at which the photoelectron wave vector *k* is 0) was also allowed to vary but was restricted to a common value for every component in a given fit. Coordination numbers were systematically varied in the course of the fit but fixed within a given fit. EXAFS data were fit over *k* = 2--13.7 Å^--1^.

EPR and ENDOR Spectroscopy {#sec2.6}
--------------------------

EPR and ENDOR experiments were conducted on unlabeled, selectively ^15^N, ^13^C-cysteine labeled, and selectively ^2^H-cysteine labeled wild type Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^. Samples containing 50% glycerol were prepared with final protein concentrations of approximately 1.0 mM. Samples were transferred to ENDOR tubes and flash frozen in liquid nitrogen. The 2 K CW EPR/ENDOR measurements at 35 GHz were performed with a spectrometer described previously^[@ref55]^ using 100 kHz field modulation and dispersion mode detection under rapid passage conditions.^[@ref56]^ The 35 GHz pulsed ^13^C MIMS ENDOR spectra were obtained using a laboratory-built spectrometer.^[@ref57],[@ref58]^

The MIMS ENDOR spectra were recorded with the pulse sequence *t*~p~--*T*--*t*~p~--τ--*t*~p~--τ-echo, where *t*~p~ is the microwave pulse duration and *T* is the duration of the applied rf pulse. Frequencies within the rf range chosen for the spectra were accessed randomly (stochastic ENDOR). Signal averaging was accomplished by collecting multiples of such spectra rather than by multiple acquisitions at each frequency.

For a single molecular orientation and for nuclei with a nuclear spin of *I* = 1/2 (^1^H, ^13^C), the ENDOR transitions for the ms =1/2 electron manifolds are observed at frequencies given by the equationwhere ν is the nuclear Larmor frequency and *A* is the orientation dependent hyperfine coupling.

Results {#sec3}
=======

Three-Dimensional NMR Experiments of Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^ {#sec3.1}
--------------------------------------------------------------------

Initially, we assumed that the NMR spectrum of apo-HO2, without paramagnetic heme (Fe^3+^; in a linear combination of *S* = 5/2 and *S* = 3/2 states), would be the best NMR assignment target. It was expected that the assignments would be transferrable to the more biologically relevant heme-bound state, since the crystal structures of the HO2 catalytic core in its heme-bound and apo forms are nearly superimposable.^[@ref24]^ However, apo-HO2^O^ showed dramatic changes in the chemical shifts when overlaid on Fe^3+^-HO2^O^ (Figure [1](#fig1){ref-type="fig"}). Moreover, apo-HO2^O^ precipitated at 30 °C during the course of the 4-h run and was thus deemed unsuitable for the long 3D assignment experiments. Therefore, studies here focused on Fe^3+^-HO2^O^, with the expectation that several residues in the heme vicinity cannot be assigned due to paramagnetic broadening. Hence, a suite of triple-resonance NMR experiments was conducted on \[U-^2^H, ^15^N, ^13^C\]-Fe^3+^-HO2^O^ for sequential backbone assignments. The construct contained residues 1--288, comprising all HRMs and lacking only the membrane-spanning region at the C-terminus.

![Overlay of the 800 MHz ^1^H- ^15^N TROSY-HSQC spectra of Fe^3+^-HO2^O^ in red with apo-HO2^O^ in blue, showing changes in chemical shifts in all parts of the protein. Inset zooms in on the crowded region in the middle of the spectrum. HO2 was present at a concentration of 250 μM in 50 mM Tris HCl, 50 mM KCl, pH 7.0 buffer. The spectra were collected at 30 °C.](bi-2014-01489r_0001){#fig1}

At concentrations above 10 μM, HO2 is homodimeric in solution as gauged by quantitative gel-filtration and NMR relaxation experiments.^[@ref59]^ Hence, it was necessary to perdeuterate the nonexchangeable sites in HO2 to improve the sensitivity and resolution in the NH-detected dimension, which occurs as a result of decreased amide proton transverse relaxation rates.^[@ref37]^ The extent of ^2^H incorporation was verified with electrospray ionization mass spectrometry (ESI-MS) analysis. A difference in molecular weight of 58 Da from an expected mass of 36 915 Da for a fully triple-labeled protein was noted, revealing 99.8% label assimilation. Sample conditions for NMR experiments were determined by testing protein stability in different buffers of pH values ranging from 4.5 to 9.0 at intervals of 0.5 pH units and acquiring several ^15^N-^1^H HSQCs for heme-bound HO2 at temperatures ranging from 15 to 45 °C at intervals of 5 °C each (data not shown). After comparing all the spectra, the optimal buffer pH and temperature for running the experiments were determined.

The ^15^N-^1^H TROSY HSQC of \[U-^2^H, ^15^N, ^13^C\]-labeled Fe^3+^-HO2^O^ is shown in Figure [2](#fig2){ref-type="fig"}. The spectrum exhibits degenerate, sharp peaks in the 7.7--8.5 ppm chemical shift region, characteristic of an intrinsically unfolded domain^[@ref60]^ and less intense, well-dispersed peaks in the remaining amide region reflective of a structured core domain. ^15^N-^1^H TROSY spectra were also collected at a larger spectral width (16.75 to −7.25 ppm) in the ^1^H dimension to identify NH peaks that may have plausibly shifted away from the typical amide proton spectral window due to paramagnetic effects. However, no additional NH peaks could be identified on either side of the normal amide range (data not shown). The spectra recorded for sequential backbone assignments included the TROSY versions of 2D ^15^N-^1^H HSQC and 3D HNCO, HN(CA)CO, HNCA, HN(CO)CA, HNCACB, and HN(CO)CACB TROSY experiments. These experiments have provided the ^13^Cα, ^13^Cβ, and ^13^CO chemical shifts of (*i*--*1*)th and (*i*)th amino acid residues to connect the adjacent amino acids through heteronuclear scalar correlations. For assignment purposes, peaks specifying the chemical shifts of various backbone nuclei of a particular residue were gathered and grouped into data cliques called generic spin systems (GS).^[@ref47]^ A total of 140 out of the 279 non-proline residues could be assigned with complete certainty. This included approximately 78% of the residues at the N-terminus that are not seen in the electron density map and 92% of the non-proline residues (34 of 37) at the C-terminus. Thus, the NMR results allow assignment of nearly all residues in the HRM-containing C-terminal domain, which were either missing in the electron density map or were not a part of the construct used in the X-ray structure determination (Figure [3](#fig3){ref-type="fig"}). Although EZ-ASSIGN and SAGA programs were entrusted for most of the assignments, some of the degenerate regions at the C-terminus had to be identified manually using strip plots in SPARKY and using specialized pseudo-4D experiments^[@ref61]^ ([Supporting Information, Figure 1](#notes-1){ref-type="notes"}).

![Overlay of the 800 MHz ^1^H-^15^N TROSY-HSQC spectrum of Fe^3+^-HO2^O^ in red and Fe^3+^-HO2^R^ in blue.](bi-2014-01489r_0002){#fig2}

![Sequence of the HO2(1--288). In blue are the residues for which no electron density was observed in the crystal structure. Yellow areas indicate assigned residues and black boxes encompass HRMs.](bi-2014-01489r_0003){#fig3}

Assignments of core residues were sparse and scattered ([Supporting Information, Figure 2](#notes-1){ref-type="notes"}). The small number of assignments of the core can directly be attributed to incomplete spin systems ([Supporting Information, Table 1](#notes-1){ref-type="notes"}).^[@ref47]^ These omissions can occur due to the combined effects of the α-helical nature of HO2, which causes crowding of peaks in the same center of the spectrum where the intense peaks of the unfolded tails occur, the large size of the protein (63 kDa for the dimer), and line-broadening caused by the paramagnetic Fe(III) center. The ferric heme in HO2 resides in a combination of *S* = 5/2 and *S* = 3/2 states. When the electron spin *T*~1~ relaxation time (τ~s~) is shorter than the rotational correlation time (τ~c~) of the protein, it is not possible to observe NMR signals of nuclei sensing the paramagnetic Fe^3+^ center.^[@ref62]^ τ~s~ for Fe^3+^ (high spin) is 10^--10^--10^--11^ s, which is much shorter than τ~c~ for the 63-kDa dimeric HO2 of 2.8 × 10^--8^ s.^[@ref59]^ Hence it is expected that the heme will broaden away the resonances for any residues within a radius of approximately 10 Å^[@ref63]^ surrounding the ferric heme-center. From distance measurements performed on the crystal structure, this would encompasses 15 residues: T41-Q49 and Y154-G159 in the proximal and distal helices, respectively. Obviously, it would be desirable to work with the HO2 protein with a diamagnetic heme; however, that state is not available in either the ferric or ferrous forms. As a next best step, the heme can be converted to a low-spin ferric (*S* = 1/2) state by azide or cyanide coordination,^[@ref64]^ which should reduce the radius of nuclei affected by paramagnetic broadening. Regretfully, no increase in the number of peaks was detected for the azide complex ([Supporting Information, Figure 3](#notes-1){ref-type="notes"}), while the cyano complex revealed a significantly reduced number of peaks (data not shown). The diamagnetic ZnPP-bound HO2^O^ was also monitored in ^15^N-^1^H TROSY HSQC to see if some of the weaker peaks would be more intense ([Supporting Information, Figure 4](#notes-1){ref-type="notes"}). However, there was *no* increase in either the intensity or the number of peaks. Together, these experiments suggest that paramagnetics is not the only cause of signal loss in oxidized HO2.

In an attempt to reduce the number of intense peaks in the center of the NMR spectrum, we also collected data on HO2 constructs in which the N-terminal region (residues 1--28) was absent. However, many chemical shift changes for the core resonances were observed, indicating deletion of this region leads to major structural/dynamical changes in the protein.

Because of the above considerations, we focused on the spectra of wild-type Fe^3+^-HO2^O^ for assignments, even though some of the resonances would be unobservable due to the paramagnetism and the crowding effect mentioned above. While the overall assignment of the NMR spectrum for HO2^O^ was not complete, most of the assignments for the C-terminal area containing the HRMs could be made (Figure [3](#fig3){ref-type="fig"}). It is to be noted that peaks pertaining to cysteines in the HRMs could not be identified in the 3D spectra, and therefore additional experiments using specifically labeled Cys (described below) were performed for their unambiguous identification. The secondary structure of the C-terminal region was delineated using the chemical shift index (CSI) method,^[@ref65],[@ref66]^ which makes use of the difference between the observed chemical shift and the random coil value assigned in an unfolded conformation to a particular amino acid type.^[@ref67]^ Random coil chemical shifts are primarily determined by the chemical composition of the side chain of a given amino acid, while chemical shifts for residues within α-helices or β-sheets are characteristic of the respective secondary structures and exhibit opposite signs, negative and positive for helices and sheets, respectively.^[@ref65]^ The resulting CSI plot (Figure [4](#fig4){ref-type="fig"}) generated for the α-carbons of residues 245--288 of Fe^3+^-HO2^O^ clearly demonstrates that this C-terminal region is present as an unfolded and dynamic random coil. CSI analysis of the N-terminal region, residues 1--28, indicates that this region also exists as an unfolded, dynamic random coil ([Supporting Information, Figure 5](#notes-1){ref-type="notes"}).

![Chemical shift index (CSI) plot of α-carbons of residues in the C-terminal tail of Fe^3+^-HO2^O^. The values of CSI for β-strand, α-helix, and random coil are +1, −1, and 0, respectively, as defined by the program CSI.^[@ref65]^ Missing indices correspond to M262, which could not be assigned and the prolines (254, 266, and 283) for which assignments cannot be determined in the H-detect experiments. The assigned secondary structure illustrates the C-terminal region to be a random coil in Fe^3+^-HO2^O^.](bi-2014-01489r_0004){#fig4}

Three-Dimensional NMR Experiments of Fe^3+^-HO2^R^ {#sec3.2}
--------------------------------------------------

Aiming to identify the changes that occur, if any, in the C-terminal tail of the reduced protein, NMR spectra of the Fe^3+^-HO2^R^ were collected. Qualitatively, the ^15^N--^1^H TROSY HSQC evinced similar spectral characteristics as those of Fe^3+^-HO2^O^ with overlapping, degenerate peaks occupying the central portion of the spectrum and dispersed, weaker peaks in the remaining amide region (Figure [2](#fig2){ref-type="fig"}); however, significant differences may be noted. Although peaks in the TROSY spectrum of Fe^3+^-HO2^R^ were generally weaker than those of Fe^3+^-HO2^O^, the disordered N-terminal region had peaks at nearly the same intensity. This indicates that the structure of the N-terminal region of HO2 is independent of the redox state of the C-terminal HRMs. In addition, this region serves as a suitable internal standard to examine peaks in the C-terminal region. Further, when compared with Fe^3+^-HO2^O^, the spectrum for Fe^3+^-HO2^R^ manifested at least 12 new peaks and disappearance of approximately seven. Unfortunately, because these 12 peaks were rather weak had incomplete GSs, we were unable to assign them. [Supporting Information, Table 1](#notes-1){ref-type="notes"} summarizes the total number of peaks picked in different spectra in HO2^O^ and HO2^R^. It is clear that Fe^3+^-HO2^O^ has significantly more GSs with a complete set of six rungs---about 106 compared to 62 for Fe^3+^-HO2^R^.

Significantly, the seven peaks that are absent in the Fe^3+^-HO2^R^ spectrum correspond to residues 267--272 in the vicinity of HRM1 (C~265~P~266~) in the C-terminal tail (Figure [5](#fig5){ref-type="fig"}). These peaks are extremely intense in the Fe^3+^-HO2^O^ spectrum, and no new peaks of similar intensity appear in the spectrum of Fe^3+^-HO2^R^. The loss of peaks most likely results from the interaction of the HRM with paramagnetic heme or from interaction of cysteines with the catalytic core.

![Portion of the ^1^H-^15^N TROSY overlay of Fe^3+^-HO2^O^ in red and Fe^3+^-HO2^R^ in blue (see Figure [1](#fig1){ref-type="fig"}), to indicate the residues that have disappeared in the reduced form.](bi-2014-01489r_0005){#fig5}

To examine if coordination of HRM-cysteine to the paramagnetic Fe^3+^ in Fe^3+^-HO2^R^ is the only cause of broadening of peaks in the C-terminal region, ^15^N-^1^H TROSY of diamagnetic ZnPP-bound HO2^O^ and HO2^R^ were collected (Figure [6](#fig6){ref-type="fig"}). Surprisingly, in the ZnPP-HO2^R^ spectrum, the same peaks (corresponding to residues 267--272) disappear, as those seen for Fe^3+^-HO2^R^. Therefore, it is unlikely that paramagnetism is the single cause of the peak disappearance in Fe^3+^-HO2^R^. Evidently, an additional effect is in play. If we hypothesize that the tail were to (transiently) dock to the core region, this would cause line-broadening effects for the HRM resonances, making them more difficult to detect and assign. We have some additional evidence that such a docking process occurs in Fe^3+^-HO2^R^. For example, in that state, some HO2 core residues were noted to undergo slow to intermediate exchange causing doubling of peaks.

![^1^H- ^15^N TROSY overlay of the ZnPP-bound HO2^O^ (blue) and HO2^R^ (orange). Inset shows residues that have completely disappeared in the HO2^R^ spectrum. These are the same residues in the C-terminal region around Cys265 as those monitored for Fe^3+^-HO2^R^. HO2 was present at a concentration of approximately 200 μM each in 50 mM Tris, 50 mM KCl, pH 7.0 buffer.](bi-2014-01489r_0006){#fig6}

Therefore, we suggest that the HRM region is no longer a dynamic random coil in the reduced state. Regretfully, because of lacking assignments, we have not been able to characterize its structure, or its docking location as of yet.

Assignment of the Cysteine Residues in the TROSY Spectra of Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^ {#sec3.3}
-------------------------------------------------------------------------------------------

As we could not identify backbone signals for the cysteine residues themselves from the 3D spectral assignment procedure, we selectively labeled the cysteine residues in HO2, allowing the unambiguous assignments of their NMR signals and serving as a direct monitor of the impact of changing redox conditions. ^15^N, ^13^C-cysteine labeled HO2 was expressed and purified as described in the [Methods](#sec2){ref-type="other"}. 3D HNCA, HN(CA)CO, and HNCACB experiments were collected in a 2D mode using parameters listed in Table [1](#tbl1){ref-type="other"} in the [Methods](#sec2){ref-type="other"}. These experiments select for residues that contain *both*^15^N and ^13^C labels, hence suppressing signals from residues that became isotopically enriched due to scrambling. NH peaks for the three cysteines of HO2 (Cys127, Cys265, and Cys282) could be observed for the HO2^O^, while none of these signals were seen in the corresponding spectra of the HO2^R^ ([Supporting Information, Figure 6](#notes-1){ref-type="notes"}). We would expect to have at least observed the signal for Cys127; however, even in the spectra of the oxidized protein, the signal for Cys127 is much weaker than those for Cys265 and Cys282. Therefore, in the reduced protein this resonance may be buried among the multitude of signals arising from the catalytic core.

Fe K-Edge EXAFS {#sec3.4}
---------------

Fe K-edge EXAFS data for wild-type Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^ and the corresponding C127A/C265A and C127A/C282A variants are presented in Figure [7](#fig7){ref-type="fig"}A--C, respectively. The spectra of wild-type and the C127A/C265A variant in the oxidized and reduced states differ between *k* ≈ 4--9 Å^--1^. This difference indicates that, upon reduction, a first shell structural change occurs at the Fe center. On the other hand, the EXAFS data for HO2^O^ and HO2^R^ of the C127A/C282A mutant are very similar over the entire EXAFS region indicating that, when Cys265 is present alone, there is little to no change in the geometric structure upon changes in redox state.

![A comparison of *k*^3^-weighted EXAFS data of (A) WT Fe^3+^-HO2° (green line), WT Fe^3+^-HO2^R^ (black line), (B) C127A/C265A Fe^3+^-HO2^O^ (blue line), C127A/C265A Fe^3+^-HO2^R^ (black line), and (C) C127A/C282A Fe^3+^-HO2^O^ (red line), C127A/C282A Fe^3+^-HO2^R^ (black line).](bi-2014-01489r_0007){#fig7}

FEFF fits were performed on the EXAFS data from all six samples. The first shell of the wild type and C127A/C265A forms of Fe^3+^-HO2^O^ were fit with 5.5 Fe--N/O components followed by single and multiple scattering component from the heme ring at higher *R* values. Since EXAFS has an ∼20% error in coordination number determination, these data are consistent with either a five- or six-coordinate first shell of light atoms. Attempts to improve the first shell by inclusion of an Fe--S component resulted in only negligible improvement (see below).

To test for the presence of an Fe--S(Cys) interaction, all data sets were fit with and without an Fe--S component. For the fits with an Fe--S component the starting structure for the first shell included 5 Fe--N (tests were also performed with 5.5 Fe--N) at ∼2.0 Å and 1 Fe--S at ∼2.25 Å, and for the fits without an Fe--S component, the starting structure for the first shell included 4 Fe--N at 2.0 Å and 0, 1, or 2 Fe--O at ∼2.1 Å. The second and third shells of EXAFS data were fit with single and multiple scattering contributions from the heme ring. Fits to *all* data sets improved (as indicated by an improvement in the goodness of fit parameter F) upon the addition of an Fe--S interaction and were consistently better than the fits without an Fe--S component. This would be expected, as addition of a weak contribution to the EXAFS data could be accommodated in the fit giving a false improvement in the *F* values. This is affirmed by the Fe--S σ^2^ value (related to Debye--Waller factor), which was characteristically high indicating either a weak interaction or partial cysteine coordination, where present.

To parse the structural differences between oxidized and reduced protein and to deterministically ascertain the presence of the Fe--S component, two fit parameters were compared: the Fe--S σ^2^ and the *change* in *F* values of the fit upon addition of the Fe--S component. The results are presented in Tables [2](#tbl2){ref-type="other"} and [3](#tbl3){ref-type="other"}. A large Fe--S σ^2^ (larger than 1000) and a small change in fit *F* value (less than 0.1) between the fits with and without Fe--S indicates negligible improvement upon addition of the Fe--S component and hence the absence of Fe--S binding. On the basis of this analysis, the best fits to the Fourier transforms and corresponding EXAFS data are presented in [Supporting Information, Figure 7](#notes-1){ref-type="notes"}, and the complete set of fit parameters are presented in [Supplemental Tables 1 and 2](#notes-1){ref-type="notes"}. The fits indicate that an Fe--S bond is not present in Fe^3+^-HO2^O^ and the C127A/C265A variant of Fe^3+^-HO2^O^, while all other systems have an Fe--S(Cys) bond (including the Fe^3+^-HO2° and Fe^3+^-HO2^R^ forms of the C127A/C282A variant). Since the C127A/C282A variant can only form an Fe--S bond using Cys265, these EXAFS data indicate that Cys265 participates in Fe--S coordination in this variant. The Fe^3+^-HO2^R^ form of C127A/C265A also shows the presence of an Fe--S component, indicating that Cys282 can also bind to the Fe site. In wild type HO2, where both Cys265 and Cys282 are present, the reduced form shows the strongest evidence for S-ligation. On the basis of the EXAFS data, either of the two cysteine residues appear to act as a ligand to Fe in wild type Fe^3+^-HO2^R^. Our structural model of a low-spin, six-coordinate heme site with an axial N(His) and a S(Cys) ligand is observed in several other protein systems, including human cystathionine beta-synthase.^[@ref68],[@ref69]^ EXAFS data on the oxidized protein show a coordination of 5 Fe--N at 1.98 Å and 1 Fe--S at 2.29 Å,^[@ref69]^ which is, within error, identical to our results, lending support to the EXAFS-based structure in the HO2 systems presented here.

###### EXAFS Fit Parameters--Bond Distances with and without (w/o) Fe--S Interaction[a](#t2fn1){ref-type="table-fn"}

                                          wild-type   C127A/C265A   C127A/C282A                                                           
  --------------------------------------- ----------- ------------- ------------- ------ ------ ------ ------ ------ ------ ------ ------ ------
  Fe--N[b](#t2fn2){ref-type="table-fn"}   2.00        1.98          2.01          2.03   2.03   1.99   2.01   2.05   2.00   2.05   2.01   2.06
  Fe--O[b](#t2fn2){ref-type="table-fn"}               2.05                        2.01          2.08          1.99          1.97          1.97
  Fe--S                                   2.21                      2.26                 2.21          2.27          2.27          2.26    

The estimated standard deviations for the distances are in the order of ±0.02 Å.

The best fits using the model without Fe--S interaction were obtained for a split first shell with 4 Fe--N and 2 Fe--O.

###### EXAFS Fit Parameters -- Fe--S σ^2^[a](#t3fn1){ref-type="table-fn"} and the Goodness of Fit Parameter F[b](#t3fn2){ref-type="table-fn"}

          wild-type   C127A/C265A   C127A/C282A                                                           
  ------- ----------- ------------- ------------- ------- ------- ------- ----- ------ ----- ------ ----- ------
  S       1147        0.25          807           0.31    1111    0.24    883   0.33   854   0.33   820   0.33
  w/o S               0.32                        0.48            0.32          0.48         0.50         0.47
  Δ                   0.07                        0.17            0.08          0.15         0.17         0.14
          not bound   bound         not bound     bound   bound   bound                                   

The σ^2^ values are multiplied by 10^5^.

Goodness of fit parameter (F) is given by Σ\[(χ~obsd~ -- χ~calcd~)^2^*k*^6^\]/Σ\[(χ~obsd~)^2^*k*^6^\].

Fe K-Edge XANES {#sec3.5}
---------------

To obtain complementary information to that obtained from Fe K-edge EXAFS analysis, the Fe K-edge XAS data for Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^ and for the corresponding double mutants, C127A/C265A and C127A/C282A, are presented in Figure [8](#fig8){ref-type="fig"}A--C, respectively. The rising edge energies (measured at 0.5 normalized intensity) for Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^ are at 7123.6 and 7122.8 eV, respectively. The values for the Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^ forms of the C127A/C265A variant are 7123.5 and 7123.0 eV, respectively, and at 7123.1 eV for the Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^ forms of the C127A/C282A variant (Table [4](#tbl4){ref-type="other"}). Both the edge positions and the spectral shape of the data presented in Figure [8](#fig8){ref-type="fig"} indicate a change in values for Fe^3+^-HO2^O^ and the C127A/C265A variant of Fe^3+^-HO2^O^ upon disulfide bond reduction to Fe^3+^-HO2^R^, while no change is indicated for the C127A/C282A variant upon reduction.

![Normalized Fe K-edge XANES spectra for HO2 protein and select mutants. (A) WT Fe^3+^-HO2^O^ (green line), WT Fe^3+^-HO2^R^ (black line), (B) C127A/C265A variant of Fe^3+^-HO2^O^ (blue line), C127A/C265A variant of Fe^3+^-HO2^R^ (black line), and (C) C127A/C282A variant of Fe^3+^-HO2^O^ (red line), reduced C127A/C282A Fe^3+^-HO2^R^ (black line).](bi-2014-01489r_0008){#fig8}

###### Edge Energy for the Wild-Type and Cysteine Variants of Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^

                edge energy                              
  ------------- ------------- ------- ----------- ------ -------
  wild-type     7123.6 eV     0.0     7122.8 eV   0.0    --0.8
  C127A/C265A   7123.5 eV     --0.1   7123.0 eV   +0.2   --0.5
  C127A/C282A   7123.1 eV     --0.5   7123.1 eV   +0.3   0.0

The shift in the rising-edge to lower energy upon disulfide bond reduction is characteristic of either a change in redox state of the iron or a switch in ligation from a light (N, O) to a heavy ligand (typically S or Cl). The redox state of iron remained ferric, since TCEP was exhaustively removed from HO2^R^ samples before Fe^3+^-heme addition, as demonstrated conclusively by EPR and UV--visible spectra (data not shown). Therefore, the observed energy shift is most likely due to a ligation change. The trends in edge data shift upon reduction in wild-type and C127A/C265A variant are consistent with the EXAFS results and indicate S binding in the disulfide-reduced form of these two proteins. The smaller shift in the C127A/C265A variant can be interpreted as a weaker coordination of Cys282 compared to Cys265, and it is expected that in wild-type Fe^3+^-HO2^R^, the dominant Fe--S coordination is via Cys265; however a smaller contribution from Cys282 cannot be ruled out based on the XAS data. In the C127A/C282A variant, the edge data for Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^ overlay and are qualitatively similar to the reduced form of wild-type and the C127A/C265A variant. This together with the EXAFS data suggest that Cys265 is bound to the Fe center in both the ^O^HO2^O^ and HO2^R^ forms of this variant.

Together, the Fe K-edge EXAFS and XANES data strongly support sulfur coordination in wild-type HO2^R^ and its variants. The data also suggest that Cys265 binds with somewhat higher affinity relative to Cys282 to the Fe center, but both cysteine residues are able to coordinate upon reduction.

EPR and ENDOR Analyses {#sec3.6}
----------------------

The X- and Q-band EPR spectra of Fe^3+^-HO2^O^ show the ferric heme to be predominantly in the high-spin state with *g*~perp~ = 5.8, and a weak low-spin signal (signal **X**) with rhombic *g*-values **g** = \[2.87, 2.26, 1.63\] (Figure [9](#fig9){ref-type="fig"}) ([Supporting Information, Figure 8](#notes-1){ref-type="notes"}). As reported earlier for myoglobin and HO1,^[@ref70]−[@ref73]^ the high- and low-spin signals are assigned to hexacoordinate Fe^3+^ heme with N/O (His/water) ligation and the low-spin signal to hexacoordinate Fe^3+^ heme, with His/OH serving as the two axial ligands. In Fe^3+^-HO2^R^, the high-spin signal (observed with Fe^3+^-HO2^O^) remains at approximately the same intensity and a new low-spin signal appears with rhombic **g** tensor, *g* = \[2.41, 2.26, 1.91\] (signal **Y**). The spectrum of Fe^3+^-HO2^R^ also contains the weak low-spin signal **X** from Fe^3+^-HO2^O^ as evidenced in the shoulder at *g* = 2.87. The new low-spin signal **Y** observed for Fe^3+^-HO2^R^ corresponds to that commonly observed for ferric heme bound with thiolate as an axial ligand.^[@ref74],[@ref75]^ The appearance of this signal without loss of intensity from heme **X** suggests that signal **Y** is associated with a second bound heme.

![Continuous wave EPR spectra of the low- and high-spin states of Fe^3+^-HO2^O^ (black) and Fe^3+^-HO2^R^ (red). (A) Dispersion mode, Q-band EPR. Experimental conditions: Temperature = 2 K, microwave frequency = 34.9 GHz, Modulation amplitude 1 G, time constant = 64 ms, scan time = 480 s, number of points = 2000. (B) X-band EPR. Experimental conditions: Temperature = 10 K, microwave frequency = 9.388 GHz, modulation amplitude 10.15 G, time constant = 40.960 ms, scan time = 671.089 s, number of points = 4096. The arrows show the *g*-values for the high and low spin state of the heme.](bi-2014-01489r_0009){#fig9}

To further characterize the low-spin ferric-heme of HO2, ^1^H and ^13^C ENDOR experiments were performed on samples in H~2~O/D~2~O buffer and on protein that had been ^2^H-Cys and ^13^C-Cys labeled. ^1^H ENDOR spectra were collected at multiple fields between *g* = 2.9 and 2.4 ([Figure S9, Supporting Information](#notes-1){ref-type="notes"}). In the spectrum taken at the *g*~1~ = 2.87 feature of signal **X** of Fe^3+^-HO2^O^ in H~2~O buffer (Figure [10](#fig10){ref-type="fig"}), there is a ^1^H signal with *A* = 10 MHz that is lost upon exchange into D~2~O buffer. In agreement with previous reports on several heme proteins,^[@ref74],[@ref76]^ this is assigned to H~*x*~O as one of the heme axial ligands in Fe^3+^-HO2^O^; histidine is the second axial ligand.

![^1^H 35 GHz CW ENDOR spectra of Fe^3+^-HO2^R^ recorded at the two unique *g* values. Spectra were recorded in H~2~O (black), D~2~O (red), or in H~2~O with ^2^H-Cys-labeled protein (green). The braces show the range of the proton coupling. Experimental conditions: Temperature, 2 K; Microwave frequency, 34.9 GHz; Modulation amplitude, 2G; RF sweep rate, 1 MHz/s; rf excitation was broadened to 100 kHz.](bi-2014-01489r_0010){#fig10}

The ^1^H ENDOR spectrum collected at *g*~1~ = 2.41 for signal **Y** of Fe^3+^-HO2^R^ (Figure [10](#fig10){ref-type="fig"}), where signal **X** gives only a minor contribution to the EPR intensity, exhibits a broad feature corresponding to *A* ≈ 7 MHz. This ^1^H ENDOR spectrum was unaffected by D~2~O exchange, indicating that the heme center responsible for signal **Y** does not have an aqua (H~*x*~O) ligand. Instead, the response at *g*~1~ = 2.41 from proton(s) with *A* ≈ 7 MHz is eliminated in a ^1^H ENDOR spectrum collected from ^2^H-Cys-labeled Fe^3+^-HO2^R^ (Figure [10](#fig10){ref-type="fig"}). This result provides direct evidence for cysteine ligation to the ferriheme of Fe^3+^-HO2^R^. The only previous investigation of hyperfine coupling to protons/deuterons of a cysteine bound to a heme iron was for a compound I.^[@ref77]^ The coupling (\<6 MHz) is slightly less than that observed for Fe^3+^-HO2^R^; however, in compound I, spin coupling between the porphyrin radical and the *S* = 1 ferryl would be expected to reduce the observed coupling. Cysteine coordination is confirmed by ^13^C MIMS ENDOR spectra of \[^13^C-Cys\]-labeled Fe^3+^-HO2^R^ (Figure [11](#fig11){ref-type="fig"}). The ^13^C MIMS ENDOR spectrum at *g*~1~ = 2.41 shows a doublet centered at the ^13^C larmor frequency, with the very small hyperfine coupling of *A*~1~ = 0.30 MHz. These peaks are absent in the unlabeled sample (black); inspection of ^13^C hyperfine spectra coupling at the three unique *g*-positions suggest that *A* is roughly isotropic, *A*~iso~ ≈ 0.3 MHz.

![^13^C MIMS ENDOR spectra of Fe^3+^-HO2^R^. Unlabeled (black), ^13^C-labeled (red). The spectra are recorded at the field positions mentioned by *g*-values. Experimental conditions; MW freq = 34.8 GHz, *T* = 2 K. pulse sequence used as discussed in Methods. tp = 50 ns, τ = 700 ns, trf = 20 μs, trep = 20 ms, no of points 256, transients/scan.](bi-2014-01489r_0011){#fig11}

The absence of the signal from the exchangeable aqua ligand for signal **Y**, and the presence of a ^13^C signal from the ^13^C-Cys labeled protein indicate that the species responsible for signal **Y** has a Cys, but not an aqua, ligand, suggesting a His/Cys coordination environment.

Discussion {#sec4}
==========

The HRM, containing a cysteine-proline (CP) diad, has recently received increasing attention as an important sequence motif in heme-binding and heme-regulated proteins.^[@ref33],[@ref35],[@ref78]^ The functional significance of the CP motif has, however, remained elusive from a structural or physiological standpoint. It has been proposed to moderate biochemical processes via cysteine ligation of the heme iron, speculated mostly through mutational analysis on a limited number of proteins.^[@ref79]^

We set out to conduct structural studies on Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^ using NMR, EPR, ENDOR, and XAS spectroscopies in order to probe if and how the HRM is involved in redox regulation of HO2. In attempts to understand the function of HRMs in HO2, our lab had previously demonstrated approximately 10-fold differential affinity of HO2 for Fe^3+^-heme that was dependent on the redox state of the two HRMs present in the C-terminal region.^[@ref26]^ However, a tryptophan fluorescence quenching study showed only a small (2.5-fold) difference in heme affinity between Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^.^[@ref28]^ Furthermore, continuous-wave electron paramagnetic resonance (CW-EPR) studies had evinced a large proportion of low-spin Fe^3+^ heme with *g*-values characteristic of thiol ligation in Fe^3+^-HO2^R^ as opposed to a predominant high-spin state indicative of His/water ligation in Fe^3+^-HO2^O^.^[@ref26]^ On the basis of these results combined with mutagenesis studies, we proposed that, in Fe^3+^-HO2^R^, Cys265 interacts with the active site heme.^[@ref26]^ However, on the basis of ^13^C-NMR and mutagenesis studies, Ortiz de Montellano's group concluded that any interactions between heme and the Cys265 thiolate are transient.^[@ref28]^

In another related study, resonance Raman (RR) revealed that the Fe^3+^-heme spin-state is not a function of the redox state of cysteines in HO2 but rather a temperature-dependent phenomenon.^[@ref29]^ In both Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^ samples, identical spectral features suggestive of the six-coordinate low-spin Fe^3+^ were observed for data collected at 77 K, while bands characteristic of high-spin Fe^3+^ heme were observed at 273 K.^[@ref29]^ An earlier RR study on HO1 had also showed an increase in the low-spin population at lower temperatures.^[@ref80]^ Both CW-EPR and RR spectroscopy are powerful techniques for revealing oxidation state, spin state, and ligands of the metal cofactor (although limited to paramagnetic species for EPR). For example, the presence of a coordinating Cys in cystathionine beta synthase (CBS) was confirmed by the detection of a Fe(III)-S(Cys) stretching mode sensitive to ^34^S-labeling.^[@ref68]^ However, further information about changes in the overall protein structure and in metal--ligand bond distances upon changes in redox state of the HRMs was needed to more fully understand the role of the HRMs in heme binding to HO2.

Given the lack of consensus about the role of the HRMs of HO2 and their ability to bind heme, we performed studies to clarify whether or not the HRMs are involved in binding heme and to reinvestigate the redox dependence and the stability of such an Fe--S interaction. The methods used in this study, including XAS, EXAFS, EPR, and ENDOR, confirm the involvement of the HRMs in heme binding when the protein is in the disulfide-reduced state (i.e., Fe^3+^-HO2^R^). From the shift of the Fe K-edge to lower energy in the reduced proteins relative to their corresponding oxidized forms, it was deduced that a heavy ligand, likely 'S', coordinates to the metal center. Furthermore, EXAFS was used to determine the atomic neighbors of the Fe^3+^ atom and their bond distances, and the results indicate that, while there is no 'S' ligand in the Fe^3+^-HO2^O^, sulfur coordination was present in Fe^3+^-HO2^R^. Lastly, ^1^H ENDOR spectra of Fe^3+^-HO2^R^ and \[^2^H-Cys\]-labeled Fe^3+^-HO2^R^ clearly demonstrate cysteine ligation and lack of water ligation in the species with a resonance at *g* = 2.41.

In addition to confirming a role for the HRMs of Fe^3+^-HO2^R^, the results of the current study address the role of the HRMs from a structural perspective. NMR results indicate that the region containing the HRMs is unstructured and mobile in Fe^3+^-HO2^O^. Seven of the strong peaks corresponding to residues 267--272 in the vicinity of Cys265 and Cys282 of the HRMs in the C-terminal region are absent from the TROSY spectrum of Fe^3+^-HO2^R^. This result supports the conclusions from ENDOR and EXAFS that the HRM is involved in paramagnetic heme coordination in this state. However, and surprisingly, upon comparing the spectra of Fe^3+^-HO2^R^ and ZnPP-bound HO2^R^, we again found that peaks corresponding to residues 267--272 were missing in the ZnPP-bound HO2^R^. Hence, while a paramagnetic effect likely is an important contributing factor, we hypothesize that the loss in signal intensity is also partially caused by (transient) docking of the HRM region on the HO2 core.

The results described here can be related to a working model (Figure [12](#fig12){ref-type="fig"}) that represents the catalytic core of HO2 as a well-structured domain that tightly binds heme in both the Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^ redox states. On the basis of our NMR results, the C-terminal tail containing the HRMs is represented as a highly mobile unstructured domain that gains some structure and docks near/on the catalytic core in the Fe^3+^-HO2^R^ state. Figure [12](#fig12){ref-type="fig"} also presents two testable models for how Fe^3+^-HO2^R^ binds heme. The first option is that the cysteine thiolate of one of the HRMs (most likely Cys265) ligates to heme bound in the catalytic site. The second option is that the HRM directly binds a second heme.

![Model describing the redox-dependence of heme binding to the HRMs of HO2. In Fe^3+^-HO2°, the thiolate of Cys265 is sequestered in a disulfide bond and is unavailable to ligate heme. However, upon reduction of the disulfide bond in Fe^3+^-HO2^R^, the free thiolate is available to bind to heme. Further studies are required to discriminate between binding of Cys265 to heme in the catalytic core or directly to a second heme in the HRM. However, as discussed in the manuscript, we favor the latter scenario.](bi-2014-01489r_0012){#fig12}

The EPR spectrum of Fe^3+^-HO2^R^ is consistent with either His/Cys or Cys/H~2~O ligation, but the ^1^H ENDOR spectrum of Fe^3+^-HO2^R^ exchanged into D~2~O clearly demonstrates that the *g* = 2.41 signal is not associated with H~2~O. Therefore, it is not unreasonable to suppose that Cys265 or Cys282 can ligate to the heme at the catalytic core with His45, providing a direct way for the protein to sense the redox state of the cell.

On the other hand, the heme in HO2 is securely sandwiched between two helices,^[@ref24]^ and the position of the heme is nearly identical in HO1,^[@ref25],[@ref30]^ which does not have HRMs. Therefore, from a structural perspective, it would be surprising for a Cys-thiolate in the C-terminal tail heme to disrupt the local structure and displace the Fe^3+^-H~2~O bond at the catalytic core of HO2 to become ligated to the catalytic site heme.

The current NMR data can neither confirm nor refute this hypothesis since assignments of the core were sparse and scattered, hence providing no structural insights into the events occurring at the catalytic site upon reduction of the disulfide bond. However, the EPR and ENDOR results favor binding of a second heme to the HRM. While Fe^3+^-HO2^O^ contains a high-spin and low-spin signal (**X**) characteristic of His/OH~*x*~ ligation, Fe^3+^-HO2^R^ contains both the high-spin heme and signal **X** associated with Fe^3+^-HO2^O^ as well as signal **Y**, suggesting that this form of the protein contains a mixture of His/water and His/Cys ligation. Since the high-spin signal associated with heme ligation at the core remains relatively the same in both Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^, the appearance of a new low spin species in Fe^3+^-HO2^R^ suggests the binding of a second heme rather than conversion of the His/water-ligated heme at the core to His/Cys. Therefore, we favor the second hypothesis described in Figure [12](#fig12){ref-type="fig"} in which Fe^3+^-HO2^R^ contains two hemes - one bound at the catalytic site and the other at the HRM.

That the HRMs could form an independent heme binding site(s) was suggested by studies from the Maines' laboratory.^[@ref31]^ Heme bound to 10-residue peptides spanning either Cys265 or Cys282 with seemingly high affinity, though with slightly higher affinity to the peptide containing Cys265.^[@ref81]^ Indeed, a recent characterization of heme binding to peptides with CP-containing motifs demonstrates that *K*~d~ values can be as low as ∼1 μM.^[@ref82]^ While these values are weak in comparison to the affinity of the catalytic site of HO2 for heme (*K*~d~ = 0.03 μM),^[@ref26]^ it suggests that in Fe^3+^-HO2^R^ heme could be bound by catalytic site in addition to one of the C-terminal HRMs. Therefore, the results presented above suggest that the weak and/or transient interactions of the HRMs with heme may be due to the lower affinity of the HRMs for heme as compared to that of the catalytic site and/or incomplete occupancy of the potential binding sites.

Recent NMR studies of a 23-mer peptide containing a CP-motif demonstrate that cofactor binding increases structural definition in the immediate vicinity of the CP motif.^[@ref82]^ The results are consistent with what was observed in our NMR studies, in which residues near the HRMs appeared to lose mobility upon reduction of the disulfide bond. Therefore, the loss of peaks corresponding to the residues near the HRMs in HO2 could be from heme binding as well as docking near the catalytic core, as suggested by results of the NMR experiments with ZnPP bound to the catalytic core of HO2.

The potential for an independent binding site(s) at the HRMs of Fe^3+^-HO2^R^ is not inconsistent with the NMR-derived hypothesis that the (heme-bound) HRM region docks on the core of HO2 upon reduction of the disulfide bond. This hypothetical docking may be important for transferring information about cellular conditions to the rest of the protein. For instance, the HRMs of HO2 have been implicated in NO sensing,^[@ref83]^ while the HRMs could reasonably be involved in sensing heme levels. In addition, as suggested by our model (Figure [12](#fig12){ref-type="fig"}), heme could be trafficked between the HRM and the catalytic core, which would necessarily involve interaction of the HRM with the catalytic core.

Experiments validating the inference that the HRMs of Fe^3+^-HO2^R^ form an independent heme binding site(s) are described in the accompanying paper,^[@ref84]^ while further experiments are underway to explore the possible role of such a site. Regardless, the results presented here imply an important role for HRMs in sensing the redox state of the cell and/or in heme homeostasis.

HNCO and HN(CA)CO spectra, backbone assignments for ^15^N, ^13^C, ^2^H Fe^3+^-HO2^O^, an overlay of the ^1^H- ^15^N TROSY of aquo-HO2 with N~3~-heme-HO2, an overlay of the ^1^H- ^15^N TROSY of heme-bound HO2 with ZnPP-bound HO2, chemical shift index plot of α-carbons of residues at the N-terminal end of HO2, 2D HNCACO overlay of Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^ with selective cysteine labeling, X-band CW EPR spectra of Fe^3+^-HO2, ^1^H 35 GHz CW ENDOR spectra of Fe^3+^-HO2^R^, the number of generic spin systems (GS) identified for each of the backbone atom types, and the chemical shifts for Cβ of oxidized and reduced apo- and holo ^15^N, ^13^C-Cys HO2, obtained from 2D CHSQC. This material is available free of charge via the Internet at <http://pubs.acs.org>.
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CSI

:   chemical shift index

DMSO

:   dimethyl sulfoxide

DTNB

:   dithiobis(nitrobenzoic acid)

ENDOR

:   electron nuclear double resonance

EPR

:   electron paramagnetic resonance

EXAFS

:   extended X-ray absorption fine structure

HO

:   heme oxygenase

HO2^O^

:   disulfide-containing heme oxygenase 2

HO2^R^

:   disulfide-reduced heme oxygenase 2

Fe^3+^-HO2^O^ and Fe^3+^-HO2^R^

:   HO2^O^ and HO2^R^ in the Fe^3+^-heme bound form, respectively

HRM

:   heme regulatory motif

HSQC

:   heteronuclear single quantum coherence

LB

:   Luria broth LB

NMR

:   nuclear magnetic resonance

TCEP

:   tris (2-carboxyethyl) phosphine hydrochloride

XANES

:   X-ray absorption near edge structure

XAS

:   X-ray absorption spectroscopy

ZnPP

:   zinc protoporphyrin
